Shine-On BioMedical Co.,Ltd. (TPEX: 6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
65.30
0.00 (0.00%)
Sep 10, 2024, 1:13 PM CST
0.62%
Market Cap 3.25B
Revenue (ttm) 9.52M
Net Income (ttm) -70.83M
Shares Out 49.80M
EPS (ttm) -1.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,201
Open 65.40
Previous Close 65.30
Day's Range 62.80 - 65.40
52-Week Range 58.50 - 68.40
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 13, 2024

About Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 19
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.